GPGrossPatternRESEARCH SYSTEM
SEC CHECK OPERATIONAL
GROSSPATTERN / FUNDAMENTAL STATE / POINT IN TIME

FSBW · Mar 31, 2026

FS Bancorp, Inc.. A multidimensional configuration derived from the filing available at this observation—never a composite score or recommendation.

STATE CAPABILITYLEVEL 3[email protected]
Inspectable configuration

State dimensions

Filing0001437749-26-015942Bank
Sequential deposit growth25thOwn-history percentile · N=20
Evidence method

Sequential · gp.financial.deposits

-1.35% · CORE · VALID

Net-income growth55thOwn-history percentile · N=20
Evidence method

Yoy · gp.fundamentals.net_income

-2.38% · CORE · VALID

Interest-income growth10thOwn-history percentile · N=20
Evidence method

Yoy · gp.financial.interest_income

5.44% · CORE · VALID

Cash and equivalents40thOwn-history percentile · N=20
Evidence method

Level · gp.fundamentals.cash

$38.7M · CORE · VALID

Sequential loan growth15thOwn-history percentile · N=20
Evidence method

Sequential · gp.financial.loans

0.04% · CORE · VALID

As-filed lineage

Fundamental state history

Each observation is tied to the filing and facts available at that report date. Amendments remain separate.

History57 statesSelf-history eligible
Period transition

What moved in the state?

Deposit Growth Decreased
Previous
-0.48%
Current
-1.35%
Delta
-0.87%
Earnings Growth Increased
Previous
-4.79%
Current
-2.38%
Delta
2.41%
Interest Income Growth Decreased
Previous
6.71%
Current
5.44%
Delta
-1.27%
Liquidity Increased
Previous
$28.2M
Current
$38.7M
Delta
$10.5M
Loan Growth Decreased
Previous
0.91%
Current
0.04%
Delta
-0.87%
Self-history only

Previous similar states

Similarity compares compatible valid dimensions from this issuer's own point-in-time history. No market-return claim is attached.

Not enough compatible prior states for a transparent self-history match.
Research Graph

Related governed research

Method Percentiles and historical matches use only observations available at each point in time. Missing dimensions remain missing. Public price outcomes and cross-market analogues are deliberately absent.